Clinical Trial Update: Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH [Phase 3]

View source ↗

Summary

A long-term extension study for inhaled nitric oxide (iNO) in pulmonary arterial hypertension is ongoing (Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Bellerophon Pulse Technologies | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: UNKNOWN